Table 3.
Effect of FloTrac/Vigileo-guided catheter therapy on hemodynamic parameters
| Experimental group (n = 20) | Control group (n = 20) | p value | |
|---|---|---|---|
| MAP (mmHg) | 71.30 ± 4.26 | 70.50 ± 3.85 | 0.54 |
| CVP (mmHg) | 10.40 ± 1.60 | 11.35 ± 1.76 | 0.08 |
| PaO2/FIO2 | 264.90 ± 19.82 | 229.50 ± 29.35 | < 0.01 |
| RVEF | 57.90 ± 5.40 | 52.20 ± 4.77 | < 0.01 |
| PASP (mmHg) | 42.10 ± 4.20 | 47.75 ± 4.04 | < 0.01 |
MAP: mean arterial pressure; CVP: central venous pressure; PaO2/FiO2: oxygenation index; RVEF: right ventricular ejection fraction; PASP: pulmonary artery systolic pressure.